摘要
一直以来,“类似结构的化学化合物可能有类似的活性”的假设,是提前量辨识的基础。这些相似性可以基于拓扑,空间位阻,电子,和/或物理性质。化学结构相似性搜索不同于化学子结构搜索,前者需要评估每个化合物的属性,因此在加快计算之前,没有过滤器可以应用于筛选结构。后者可以加速通过预筛选化合物,从查询结果中忽略一个(或多个)指定的碎片。此外,三维相似搜索需要叠加许多数据库中化合物的构象对。这使得三维相似性搜索算法十分耗时,并且一般需要高性能计算(HPC)资源。本文对基于HPC技术的二维和三维化学结构相似性搜索的最新研究进展,以及它们在基于配体的虚拟筛选应用进行了讨论。
关键词: 化学信息学、药物发现,HPC,基于配体的虚拟筛选,结构相似性搜索。化学信息学、药物发现,HPC,基于配体的虚拟筛选,结构相似性搜索。
图形摘要
Current Drug Targets
Title:Chemical Structure Similarity Search for Ligand-based Virtual Screening: Methods and Computational Resources
Volume: 17 Issue: 14
Author(s): Xin Yan, Chenzhong Liao, Zhihong Liu, Arnold T. Hagler, Qiong Gu, Jun Xu
Affiliation:
关键词: 化学信息学、药物发现,HPC,基于配体的虚拟筛选,结构相似性搜索。化学信息学、药物发现,HPC,基于配体的虚拟筛选,结构相似性搜索。
摘要: For many years the assumption that “Chemical compounds with similar structures may have similar activities” has been a foundation for lead identification. The similarity can be computed based upon topological, steric, electronic, and/or physical properties. The chemical structure similarity search differs from the chemical substructure search in that the former requires assessment of the properties of each compound and thus no filter can be applied for skipping structures before they are assessed to accelerate the computation. The latter can be accelerated by pre-screening compounds and omitting those that miss one (or more) specified fragments from the query. Moreover, three-dimensional similarity search requires superimposing many conformation pairs for each compound in the library. This makes 3-D similarity search algorithms time-consuming, and in general requires high performance computing (HPC) resources. This review will summarize recent progress in the techniques for HPC-supported two and three-dimensional chemical structure similarity search algorithms, and their applications in ligand-based virtual screening.
Export Options
About this article
Cite this article as:
Xin Yan, Chenzhong Liao, Zhihong Liu, Arnold T. Hagler, Qiong Gu, Jun Xu , Chemical Structure Similarity Search for Ligand-based Virtual Screening: Methods and Computational Resources, Current Drug Targets 2016; 17 (14) . https://dx.doi.org/10.2174/1389450116666151102095555
DOI https://dx.doi.org/10.2174/1389450116666151102095555 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers